Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Carmelo Nucera, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Carmelo Nucera and Dora Dias-Santagata.
Connection Strength

0.405
  1. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model. Oncotarget. 2015 Dec 15; 6(40):42445-67.
    View in: PubMed
    Score: 0.161
  2. Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis. Endocr Relat Cancer. 2015 Dec; 22(6):L23-8.
    View in: PubMed
    Score: 0.160
  3. Invasive follicular variant of papillary thyroid cancer harboring the NRAS mutation Q61K and presenting with bone metastasis-A case report. Int J Surg Case Rep. 2017; 38:180-184.
    View in: PubMed
    Score: 0.045
  4. Genomic and immunohistochemical analysis in human adrenal cortical neoplasia reveal beta-catenin mutations as potential prognostic biomarker. Discoveries (Craiova). 2015 Apr-Jun; 3(2).
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.